Development Level

Tbio 86 | 10,625
Tdark 65 | 7,003
Tchem 2 | 1,890
Tclin 2 | 602

Collection

Eligible non-olfactory GPCR Proteins 1 | 143

IMPC Term

abnormal behavior 3 | 226
decreased lean body mass 3 | 195
decreased total body fat amoun... 3 | 186
abnormal gait 2 | 51
corneal opacity 2 | 25
increased bone mineral content 2 | 92
increased hemoglobin content 2 | 45
increased mean corpuscular hem... 2 | 93
increased mean corpuscular vol... 2 | 91
tremors 2 | 34
abnormal coat appearance 1 | 25
abnormal cornea morphology 1 | 24
abnormal ear morphology 1 | 5
abnormal lens morphology 1 | 73
abnormal locomotor activation 1 | 26
abnormal startle reflex 1 | 14
abnormal tail movements 1 | 12
abnormal urination 1 | 2
absent startle reflex 1 | 15
corneal vascularization 1 | 5
decreased body weight 1 | 174
decreased bone mineral content 1 | 157
decreased bone mineral density 1 | 126
decreased circulating alanine ... 1 | 53
decreased circulating calcium ... 1 | 33
decreased circulating creatini... 1 | 31
decreased circulating insulin ... 1 | 75
decreased circulating triglyce... 1 | 83
decreased grip strength 1 | 123
decreased lumbar vertebrae num... 1 | 62
decreased prepulse inhibition 1 | 52
decreased startle reflex 1 | 48
decreased vertical activity 1 | 22
hyperactivity 1 | 108
increased body weight 1 | 42
increased bone mineral density 1 | 52
increased circulating creatini... 1 | 29
increased circulating iron lev... 1 | 25
increased circulating sodium l... 1 | 71
increased circulating thyroxin... 1 | 7
increased grip strength 1 | 83
increased lean body mass 1 | 107
increased or absent threshold ... 1 | 128
increased vertical activity 1 | 18
narrow eye opening 1 | 15
persistence of hyaloid vascula... 1 | 22
short snout 1 | 4
short tibia 1 | 82
shortened ST segment 1 | 9
shortened head 1 | 2
straub tail 1 | 26
thrombocytopenia 1 | 46

Disease

Carcinoma 91 | 2,147
psoriasis 63 | 6,685
osteosarcoma 53 | 7,933
medulloblastoma, large-cell 52 | 6,234
lung carcinoma 49 | 2,844
ovarian cancer 49 | 8,484
glioblastoma 48 | 5,572
atypical teratoid / rhabdoid tumor 47 | 4,369
Breast cancer 35 | 3,094
pilocytic astrocytoma 34 | 3,086
group 4 medulloblastoma 33 | 1,875
oligodendroglioma 33 | 2,849
lung adenocarcinoma 29 | 2,713
lung cancer 29 | 4,466
non-small cell lung cancer 29 | 2,798
primitive neuroectodermal tumor 28 | 3,031
intraductal papillary-mucinous neoplasm (IPMN) 27 | 3,289
invasive ductal carcinoma 27 | 2,950
intraductal papillary-mucinous carcinoma (IPMC) 25 | 2,988
malignant mesothelioma 25 | 3,162
pediatric high grade glioma 25 | 2,712
adult high grade glioma 24 | 2,148
astrocytic glioma 23 | 2,241
interstitial cystitis 23 | 2,299
pituitary cancer 23 | 1,972
Cancer 22 | 2,346
ependymoma 22 | 2,514
intraductal papillary-mucinous adenoma (IPMA) 22 | 2,956
subependymal giant cell astrocytoma 19 | 2,287
medulloblastoma 18 | 1,524
pancreatic cancer 18 | 2,300
posterior fossa group A ependymoma 18 | 1,511
ulcerative colitis 18 | 2,087
ductal carcinoma in situ 16 | 1,745
posterior fossa group B ependymoma 16 | 1,530
breast carcinoma 14 | 1,614
cystic fibrosis 14 | 1,665
sonic hedgehog group medulloblastoma 14 | 1,482
Pick disease 13 | 1,893
atypical teratoid/rhabdoid tumor 12 | 1,095
primary pancreatic ductal adenocarcinoma 12 | 1,271
colon cancer 11 | 1,475
cutaneous lupus erythematosus 11 | 1,056
esophageal adenocarcinoma 11 | 737
active Crohn's disease 10 | 918
astrocytoma 10 | 1,493
Autistic Disorder 9 | 320
Multiple Sclerosis 9 | 498
group 3 medulloblastoma 9 | 2,254
Rheumatoid Arthritis 8 | 1,160
spina bifida 8 | 1,064
Intellectual disability 7 | 573
Kidney cancer 7 | 118
Schizophrenia 7 | 501
aldosterone-producing adenoma 7 | 664
fibroadenoma 7 | 557
urothelial carcinoma 7 | 318
Atopic dermatitis 6 | 944
Colorectal Neoplasms 6 | 217
Duchenne muscular dystrophy 6 | 602
Hypotrichosis 6 | 29
Obesity 6 | 616
Ritter's disease 6 | 10
adrenocortical carcinoma 6 | 1,427
head and neck cancer 6 | 270
nasopharyngeal carcinoma 6 | 1,056
Alzheimer's disease 5 | 644
Atherosclerosis 5 | 275
Down syndrome 5 | 548
Endometriosis 5 | 535
Mammary Neoplasms 5 | 410
autosomal dominant Emery-Dreifuss muscular dystrophy 5 | 499
gastric carcinoma 5 | 832
juvenile dermatomyositis 5 | 1,189
mucosa-associated lymphoid tissue lymphoma 5 | 480
non primary Sjogren syndrome sicca 5 | 840
non-small cell lung carcinoma 5 | 413
Acquired metabolic disease 4 | 267
Asthma 4 | 349
Crohn's disease 4 | 304
Prostatic Neoplasms 4 | 471
Spontaneous abortion 4 | 108
Squamous cell carcinoma of esophagus 4 | 82
Usher syndrome 4 | 34
Vascular disease 4 | 281
adrenocortical adenoma 4 | 134
nephrosclerosis 4 | 329
primary Sjogren syndrome 4 | 789
sarcoidosis 4 | 358
Dermatitis 3 | 107
Heart disease 3 | 279
Kidney disease 3 | 396
Waldenstrons macroglobulinemia 3 | 765
acute myeloid leukemia 3 | 780
acute quadriplegic myopathy 3 | 1,157
chronic lymphosyte leukemia 3 | 232
chronic rhinosinusitis 3 | 512
dermatomyositis 3 | 933
periodontitis 3 | 269
tuberculosis 3 | 1,557

Tissue

Digestive Tract 154 | 18,473
Female tissues 154 | 18,647
Liver and Pancreas 154 | 18,136
Cardiovascular System 153 | 17,958
Nervous System 153 | 18,561
Urinary Tract 153 | 18,444
Blood and immune system 152 | 17,995
Endocrine System 152 | 18,512
Male tissues 152 | 17,969
Respiratory system 150 | 17,484
Skin and soft tissues 150 | 18,115

Target Family

Non-IDG 148 | 11,971
GPCR 3 | 406
Enzyme 2 | 4,146
Kinase 2 | 634

GO Process

homophilic cell adhesion via p... 155 | 155
transcription, DNA-templated 1,779 | 1,779
regulation of transcription, D... 1,170 | 1,170
signal transduction 969 | 969
positive regulation of transcr... 845 | 845
G-protein coupled receptor sig... 666 | 666
negative regulation of transcr... 620 | 620
apoptotic process 506 | 506
positive regulation of transcr... 504 | 504
negative regulation of transcr... 483 | 483
multicellular organism develop... 456 | 456
positive regulation of cell pr... 451 | 451
cell differentiation 442 | 442
negative regulation of apoptot... 440 | 440
innate immune response 410 | 410
cell adhesion 409 | 409
immune response 398 | 398
negative regulation of cell pr... 379 | 379
inflammatory response 371 | 371
viral process 368 | 368
spermatogenesis 365 | 365
cell proliferation 358 | 358
protein transport 356 | 356
intracellular signal transduct... 355 | 355
cell division 330 | 330
regulation of transcription fr... 324 | 324
protein phosphorylation 320 | 320
response to drug 297 | 297
positive regulation of apoptot... 292 | 292
nervous system development 275 | 275
transcription from RNA polymer... 272 | 272
cell surface receptor signalin... 267 | 267
protein ubiquitination 260 | 260
transport 257 | 257
cell-cell signaling 249 | 249
regulation of immune response 247 | 247
positive regulation of gene ex... 242 | 242
mitotic nuclear division 241 | 241
MAPK cascade 238 | 238
chemical synaptic transmission 238 | 238
mRNA splicing, via spliceosome 219 | 219
angiogenesis 218 | 218
small GTPase mediated signal t... 215 | 215
translation 215 | 215
rRNA processing 209 | 209
intracellular protein transpor... 205 | 205
cellular response to DNA damag... 201 | 201
cell cycle 200 | 200
proteasome-mediated ubiquitin-... 200 | 200
proteolysis 199 | 199
visual perception 198 | 198
DNA repair 196 | 196
extracellular matrix organizat... 193 | 193
regulation of apoptotic proces... 190 | 190
brain development 183 | 183
positive regulation of cell mi... 181 | 181
protein polyubiquitination 181 | 181
in utero embryonic development 178 | 178
Fc-epsilon receptor signaling ... 176 | 176
Wnt signaling pathway 175 | 175
ion transmembrane transport 174 | 174
protein homooligomerization 173 | 173
heart development 170 | 170
positive regulation of ERK1 an... 170 | 170
blood coagulation 169 | 169
cell migration 168 | 168
regulation of cell proliferati... 167 | 167
protein autophosphorylation 166 | 166
response to hypoxia 164 | 164
mRNA processing 162 | 162
negative regulation of canonic... 162 | 162
protein folding 162 | 162
T cell receptor signaling path... 161 | 161
response to lipopolysaccharide 161 | 161
defense response to virus 160 | 160
RNA splicing 158 | 158
aging 158 | 158
positive regulation of I-kappa... 158 | 158
axon guidance 157 | 157
sensory perception of smell 155 | 155
ER to Golgi vesicle-mediated t... 151 | 151
interferon-gamma-mediated sign... 150 | 150
protein ubiquitination involve... 150 | 150
transcription initiation from ... 150 | 150
ubiquitin-dependent protein ca... 149 | 149
DNA replication 144 | 144
adaptive immune response 139 | 139
cell cycle arrest 139 | 139
receptor-mediated endocytosis 139 | 139
skeletal system development 136 | 136
regulation of cell shape 135 | 135
regulation of small GTPase med... 134 | 134
G2/M transition of mitotic cel... 133 | 133
oxidation-reduction process 133 | 133
positive regulation of cytosol... 133 | 133
protein stabilization 133 | 133
sensory perception of sound 132 | 132
positive regulation of NF-kapp... 131 | 131
antigen processing and present... 130 | 130
type I interferon signaling pa... 130 | 130

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Calsyntenin-1 CLSTN1 Tbio Non-IDG -1.08669 14.3 106
Kin of IRRE-like protein 3 KIRREL3 Tbio Non-IDG -1.37511 25.5 78
Carcinoembryonic antigen-related cell adhesion molecule 1 CEACAM1 Tbio Non-IDG -2.42637 343.3 423
Desmocollin-1 DSC1 Tbio Non-IDG -1.36419 21.9 119
Cell adhesion molecule 4 CADM4 Tbio Non-IDG -1.02667 13.5 184
Cadherin-19 CDH19 Tdark Non-IDG -0.58418 4.04 107
Protocadherin alpha-C1 PCDHAC1 Tdark Non-IDG 1.66 33
Cadherin-related family member 3 CDHR3 Tdark Non-IDG -0.78941 7.95 33
Plexin-B2 PLXNB2 Tbio Non-IDG -1.15381 13.4 86
Plexin-B3 PLXNB3 Tbio Non-IDG -0.88703 9.74 43